Tradestie Institutional Equity Comparison Engine
OLMA vs AURA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
AURA Overall Edge
AURA Captures Institutional Edge (3โ0 Pillars ยท 4โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Aura Biosciences, Inc. Common Stock (AURA) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, OLMA trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus AURA at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, OLMA sits in BREAKDOWN (30th %ile IV; Dealer Gamma Walls on Pro) against AURA sits in CONSOLIDATION (22nd %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
OLMA N/M vs AURA N/M Fwd P/E
Growth & Margin Winner
AURA
Op Margin 0.0% vs 0.0% ยท YoY +0.0% vs +0.0%
Momentum & Technical Winner
AURA
1Y -9.9% vs +30.4% ยท 52W Pos 3% vs 52%
Options & Structure Winner
AURA
BREAKDOWN (30th %ile IV) vs CONSOLIDATION (22nd %ile IV)
OLMA
NASDAQ
Olema Pharmaceuticals, Inc. Common Stock
Pharmaceutical Preparations
$7.15
-5.42% 1D
Market Cap
$658.8M
1M Return
+8.66%
1Y Return
-9.95%
Forward P/E
N/M
Unified AI Score
47.0 / 100
HOLD
Tech 43.0
Fund 51.0
Flow 68.0
Mom 60.0
AURA
NASDAQ
Aura Biosciences, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$7.21
+1.41% 1D
Market Cap
$728.6M
1M Return
+18.2%
1Y Return
+30.38%
Forward P/E
N/M
Unified AI Score
28.8 / 100
SELL
Tech 50.0
Fund 39.0
Flow 71.0
Mom 44.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
OLMA -9.95%
AURA +30.38%
Spread: +40.33 pp (AURA Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
OLMA TTM Op. Margin: 0.0%
AURA TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on OLMA vs AURA. Trailing 12-month operating profitability (OLMA 0.0% vs AURA 0.0%) and valuation multiples (OLMA N/M vs AURA N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | OLMA | AURA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $658.8M | $728.6M | Larger Scale | AURA |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | +0.0% | Higher Growth | Tie |
| Operating Margin (TTM) Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Net Profit Margin Profitability | 0.0% | 0.0% | Higher Margin | Tie |
| Return on Equity (ROE) Capital Efficiency | -69.8% | -61.7% | Higher ROE | AURA |
| 52-Week Range Position Momentum | 3% ($6โ$36) | 52% ($5โ$10) | Stronger Trend | AURA |
| Beta / 30D Volatility Risk Regime | 1.83ฮฒ ยท 86% Vol | 0.92ฮฒ ยท 75% Vol | Lower Realized Risk | AURA |
| Unified Institutional Score Composite Signal | 47.0 / 100 (HOLD) | 28.8 / 100 (SELL) | Higher Composite | OLMA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full OLMA vs AURA Buy Guide
OLMA
BREAKDOWN
94d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
30th %ile
IV Regime
Balanced (25thโ60th %ile)
AURA
CONSOLIDATION
135d in phase ยท OBV DISTRIBUTION
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
22nd %ile
IV Regime
Compressed (<25th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither OLMA nor AURA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.